77.56
0.77%
+0.59
시간 외 거래:
77.56
Biomarin Pharmaceutical Inc. 주식(BMRN)의 최신 뉴스
Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff - BioSpace
BioSpace
Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff - BioSpace
BioSpace
Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff - BioSpace
BioSpace
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript - MSN
MSN
Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff - BioSpace
BioSpace
Walmart To Rally Over 17%? Here Are 10 Top Analyst Forecasts For Friday - Walmart (NYSE:WMT) - Benzinga
Benzinga
BioMarin stock downgraded by Baird amid BridgeBio study data - Investing.com
Investing.com
Q2 2024 EPS Estimates for BioMarin Pharmaceutical Inc. Decreased by Analyst (NASDAQ:BMRN) - Defense World
Defense World
Amgen’s Imdelltra Becomes First Bi-specific T-cell engager for Advanced SCLC - BioSpace
BioSpace
Biotech company lays off over a hundred Bay Area workers - SFGATE
SFGATE
BMS’s Breyanzi Secures Fourth FDA Approval, for Follicular Lymphoma - BioSpace
BioSpace
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) to Post Q2 2024 Earnings of $0.36 Per Share, Zacks Research Forecasts - MarketBeat
MarketBeat
Zacks Research Comments on BioMarin Pharmaceutical Inc.'s Q3 2024 Earnings (NASDAQ:BMRN) - Defense World
Defense World
Biopharma Layoff Tracker 2024: Bolt, Tenaya, BioMarin and More Cut Staff - BioSpace
BioSpace
BioMarin to reduce global workforce by approximately 170 employees - TipRanks.com - TipRanks
TipRanks
Q3 2024 EPS Estimates for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Increased by Zacks Research - MarketBeat
MarketBeat
BioMarin: Short-Term Headwinds But Long-Term Opportunities Remain - Seeking Alpha
Seeking Alpha
BioMarin sheds 170 jobs in wake of narrowed R&D refocus - Fierce Biotech
Fierce Biotech
Novo Holdings buys stake in life sciences tools company; BioMarin lays off 170 - Yahoo Finance
Yahoo Finance
BioMarin Pharmaceutical (NASDAQ:BMRN) Now Covered by Analysts at Evercore ISI - Defense World
Defense World
Biopharma Layoff Tracker 2024: Bolt, Tenaya, BioMarin and More Cut Staff - BioSpace
BioSpace
BioMarin cutting about 170 jobs after shuffling drug portfolio - The Business Journals
The Business Journals
BioMarin Pharmaceutical to lay off 170 employees (NASDAQ:BMRN) - Seeking Alpha
Seeking Alpha
Evercore ISI Initiates Coverage on BioMarin Pharmaceutical (NASDAQ:BMRN) - MarketBeat
MarketBeat
Analyst Ratings For Biomarin Pharmaceutical
Benzinga
Amalgamated Bank Decreases Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Defense World
Defense World
Benjamin F. Edwards & Company Inc. Boosts Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Defense World
Defense World
Are BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market? - Simply Wall St
Simply Wall St
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Director Jean Jacques Bienaime Sells 20000 Shares - Defense World
Defense World
Thornburg Investment Management Inc. Sells 105,276 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
MarketBeat
Biomarin executive sells over $3.25 million in company stock - Investing.com India
Investing.com India
Biomarin executive sells over $3.25 million in company stock - Investing.com
Investing.com
BioMarin shares receive Outperform rating on new leadership - Investing.com India
Investing.com India
Jean Jacques Bienaime Sells 20,000 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stock - MarketBeat
MarketBeat
BioMarin Pharmaceutical (BMRN) Q2 Earnings and Revenues Surpass Estimates - Yahoo New Zealand News
Yahoo New Zealand News
Metis Global Partners LLC Sells 245 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Defense World
Defense World
Charles Schwab Investment Management Inc. Raises Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
MarketBeat
BioMarin (BMRN) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Singapore News
Yahoo Singapore News
BioMarin Pharmaceutical (BMRN) Stock Forecast and Price Target 2024 - MarketBeat
MarketBeat
6911 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Bought by Los Angeles Capital Management LLC - Defense World
Defense World
Natixis Advisors L.P. Reduces Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Defense World
Defense World
Fisher Asset Management LLC Acquires New Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat
MarketBeat
What Can We Conclude About BioMarin Pharmaceutical's (NASDAQ:BMRN) CEO Pay? - Yahoo Canada Shine On
Yahoo Canada Shine On
13266 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Acquired by Fisher Asset Management LLC - Defense World
Defense World
International Assets Investment Management LLC Acquires New Holdings in BioMarin Pharmaceutical Inc. (NASDAQ ... - Defense World
Defense World
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
MarketBeat
(BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest - Biomarin Pharmaceutical (NASDAQ:BMRN) - Benzinga
Benzinga
Why You Shouldn't Bet Against BioMarin Pharmaceutical (BMRN) Stock - Yahoo News UK
Yahoo News UK
The 3 Best Biotech Stocks to Buy in May 2024 - InvestorPlace
InvestorPlace
BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1 ... - PR Newswire
PR Newswire
자본화:
|
볼륨(24시간):